CEO total pay
$13,809,549
Prahlad R. Singh · 2025
Say on pay
Not disclosed
Use Ask for the underlying narrative
CEO pay ratio
Item 402(u)239 to 1
Median employee: $57,745
Compensation committee
Committee ReportCompensation Committee
Per the latest proxy
Filings indexed: 2 · 2026 · 2025
Executive pay
What did they pay them?
From the Summary Compensation Table. Pay mix and YoY are computed from these rows.
| Executive | Role | TotalYoY | Pay mix | Salary | Stock | Cash incentive | Other |
|---|---|---|---|---|---|---|---|
Prahlad R. Singh2025 compensation | Chief Executive Officer | $13,809,549↑ 16% | 92% at-risk | $1,129,231 | $7,694,985 | $2,385,450 | $40,731 |
Maxwell Krakowiak2025 compensation | Senior Vice President and Chief Financial Officer | $5,372,814↑ 66% | 89% at-risk | $550,577 | $2,099,940 | $598,920 | $27,620 |
Miriame Victor2025 compensation | Senior Vice President and Chief Commercial Officer | $4,096,074↑ 65% | 87% at-risk | $503,269 | $1,530,069 | $509,082 | $26,738 |
Joel S. Goldberg2025 compensation | Senior Vice President, Administration, General Counsel and Secretary | $3,668,457↑ 8% | 83% at-risk | $564,616 | $1,816,849 | $636,120 | $46,636 |
Tajinder S. Vohra2025 compensation | Senior Vice President, Global Operations | $2,639,228↑ 14% | 80% at-risk | $489,615 | $1,206,519 | $515,592 | $26,227 |
Pay mix: base cash incentive equity other
CD&A excerpt
Compensation discussion & analysis
Opening passage of the loaded filing's CD&A. Use Ask below to query the full text with citations.
Read the full CD&A on SEC.gov ↗
Peer comparison
Who they benchmark against
Click any peer to jump to their proxy. Peers we haven't ingested yet kick off an import on click.
2025 Peer Group
12 members · 6 in ProxyMiner
2025 Compensation Peer Group
29 members · 10 in ProxyMiner
PSTV · PLUS THERAPEUTICS, INC.TXG · 10x Genomics, Inc.QDEL · QuidelOrtho CorpA · AGILENT TECHNOLOGIES, INC.ILMN · ILLUMINA, INC.RGEN · REPLIGEN CORPAVTR · Avantor, Inc.IQV · IQVIA HOLDINGS INC.ROP · ROPER TECHNOLOGIES INCBDX · BECTON DICKINSON & COBAC · BANK OF AMERICA CORP /DE/BIO · BIO-RAD LABORATORIES, INC.MEDP · Medpace Holdings, Inc.TDY · TELEDYNE TECHNOLOGIES INCTECH · BIO-TECHNE CorpMTD · METTLER TOLEDO INTERNATIONAL INC/TFX · TELEFLEX INCBRKR · BRUKER CORPMYGN · MYRIAD GENETICS INCCOO · COOPER COMPANIES, INC.CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.NTRA · Natera, Inc.TMO · THERMO FISHER SCIENTIFIC INC.DHR · DANAHER CORP /DE/NEOG · NEOGEN CORPWAT · WATERS CORP /DE/QGEN · QIAGEN N.V.HAE · HAEMONETICS CORPDGX · QUEST DIAGNOSTICS INC
Governance
Policy guardrails
hedging
✔ What We Do x What We Don’t Do Clawback policy on incentive plans and certain stock option gains No hedging or pledging of company stock Meaningful stock ownership guidelines for our executives and directors No excise tax gross-ups (new employment agreements entered into after J
“✔ What We Do x What We Don’t Do Clawback policy on incentive plans and certain stock option gains No hedging or pledging of company stock Meaningful stock ownership guidelines for our executives and directors No excise t…”
pledging
prohibited
“The policy also prohibits pledging of Revvity stock by our officers.”
clawback
present
“clawback policy and adopted revisions to the Global ICP plan recoupment provision in accordance with rules promulgated by the U.S”
stock ownership guidelines
present
“Stock Ownership Guidelines”
change in control
In addition, effective upon a change in control, 100% of Mr
“In addition, effective upon a change in control, 100% of Mr”
compensation consultant
independent
“independent compensation consultant”
compensation committee
Compensation Committee
“Compensation Committee Report”
Performance markers
Metric facts
relative tsr
28th percentile
“Relative TSR achievement against the peer group was at the 28th percentile, resulting in no upward or downward modification of the calculated financial results.”
revenue
$101.1 million
“company we have become, all while bringing significant new innovations to the market. Collectively and individually, our leadership team delivered differentiated performance despite market headwinds, demonstrating the st…”
operating income
$357 million
“per share from continuing operations of $2.30 for fiscal year 2024. Adjusted earnings per share from continuing operations for fiscal year 2025 was $5.06, as compared to $4.90 for fiscal year 2024. • GAAP revenue for fis…”
time equity mix
50%
“In October 2023, the committee approved our equity choice program for the officers of the Company participating in the LTIP, beginning with the 2024 LTIP, which enables the officers to choose to receive additional stock …”
ceo pay ratio
239 to 1
“Compensation Table appearing on page 51, the 2025 annual total compensation as determined under Item 402 of Regulation S-K for our CEO was $13,809,549. The 2025 annual total compensation as determined under Item 402 of R…”
median employee compensation
$57,745
“for purposes of making our determination. As disclosed in the Summary Compensation Table appearing on page 51, the 2025 annual total compensation as determined under Item 402 of Regulation S-K for our CEO was $13,809,549…”
Ask
Anything about REVVITY, INC.’s 2026 proxy
Answers are grounded in the loaded filing and cite specific artifacts. Bring your own free Google AI Studio key.
Loading the Ask interface…